Entrada Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.3M | 222k | 5.80 |
| 2025-03-31 | $837k | 93k | 9.04 |
| 2024-12-31 | $4.9M | 285k | 17.29 |
| 2024-09-30 | $1.3M | 85k | 15.98 |
| 2024-06-30 | $475k | 33k | 14.25 |
| 2024-03-31 | $246k | 17k | 14.17 |
| 2023-12-31 | $273k | 18k | 15.09 |
| 2023-09-30 | $202k | 13k | 15.80 |
| 2023-06-30 | $323k | 21k | 15.14 |
| 2023-03-31 | $684k | 47k | 14.50 |
| 2022-12-31 | $5.4M | 402k | 13.52 |
| 2022-06-30 | $5.4M | 446k | 12.18 |
| 2022-03-31 | $4.2M | 446k | 9.39 |
| 2021-12-31 | $7.6M | 446k | 17.12 |